Shen C, Qiu Z, Song H, Wei W, Luo Q. miRNA-106a directly targeting RARB associates with the expression of Na(+)/I(-) symporter in thyroid cancer by regulating MAPK signaling pathway. J Exp Clin Cancer Res. 2016;35:101 pubmed publisher

Zhang H, Meng J, Li X, Zhou S, Qu D, Wang N, et al. Pro-GLP-1, a Pro-drug of GLP-1, is neuroprotective in cerebral ischemia. Eur J Pharm Sci. 2015;70:82-91 pubmed publisher

Zhu X, Bai Y, Yu W, Pan C, Jin E, Song D, et al. The effects of pleiotrophin in proliferative diabetic retinopathy. PLoS ONE. 2015;10:e0115523 pubmed publisher

Vignarajan S, Xie C, Yao M, Sun Y, Simanainen U, Sved P, et al. Loss of PTEN stabilizes the lipid modifying enzyme cytosolic phospholipase A?? via AKT in prostate cancer cells. Oncotarget. 2014;5:6289-99 pubmed publisher

Zinn R, Gardner E, Marchionni L, Murphy S, Dobromilskaya I, Hann C, et al. ERK phosphorylation is predictive of resistance to IGF-1R inhibition in small cell lung cancer. Mol Cancer Ther. 2013;12:1131-9 pubmed publisher

Burkhard K, Shapiro P. Use of inhibitors in the study of MAP kinases. Methods Mol Biol. 2010;661:107-22 pubmed publisher